Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Heparin"" wg kryterium: Temat


Tytuł:
Heparinase III with High Activity and Stability: Heterologous Expression, Biochemical Characterization, and Application in Depolymerization of Heparin.
Autorzy:
Xu CL; School of Pharmacy, Jiangsu University, Zhenjiang 212013, People's Republic of China.
Zhu CY; School of Pharmacy, Jiangsu University, Zhenjiang 212013, People's Republic of China.
Li YN; School of Pharmacy, Jiangsu University, Zhenjiang 212013, People's Republic of China.
Gao J; School of Grain Science and Technology, Jiangsu University of Science and Technology, Zhenjiang 212004, People's Republic of China.
Zhang YW; School of Pharmacy, Jiangsu University, Zhenjiang 212013, People's Republic of China.
Pokaż więcej
Źródło:
Journal of agricultural and food chemistry [J Agric Food Chem] 2024 Feb 14; Vol. 72 (6), pp. 3045-3054. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/analysis
Heparin*/chemistry
Heparin*/metabolism
Polysaccharide-Lyases*/genetics
Polysaccharide-Lyases*/metabolism
Heparin Lyase/genetics ; Heparin Lyase/chemistry ; Heparin Lyase/metabolism ; Binding Sites
Czasopismo naukowe
Tytuł:
New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry.
Autorzy:
Shi D; National Glycoengineering Research Center, Shandong University, Qingdao, Shandong Province, China; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA.
Zhao H; National Glycoengineering Research Center, Shandong University, Qingdao, Shandong Province, China.
Bu C; National Glycoengineering Research Center, Shandong University, Qingdao, Shandong Province, China.
Fraser K; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA.
Wang H; National Glycoengineering Research Center, Shandong University, Qingdao, Shandong Province, China.
Dordick JS; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA.
Linhardt RJ; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York, USA.
Zhang F; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York, USA; Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA. Electronic address: .
Shi F; Shandong Institute for Food and Drug Control, Jinan, Shandong Province, China. Electronic address: .
Chi L; National Glycoengineering Research Center, Shandong University, Qingdao, Shandong Province, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Dec; Vol. 21 (12), pp. 3608-3618. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*
Platelet Factor 4*
Thrombocytopenia*/chemically induced
Humans ; Enoxaparin/adverse effects ; Heparin, Low-Molecular-Weight/adverse effects ; Immunologic Factors/adverse effects ; Mass Spectrometry ; Oligosaccharides/adverse effects
Czasopismo naukowe
Tytuł:
Zn Differentially Influences the Neutralisation of Heparins by HRG, Fibrinogen, and Fibronectin.
Autorzy:
Sobczak AIS; School of Medicine, University of St Andrews, St. Andrews KY16 9TF, UK.
Ajjan RA; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 3AA, UK.
Stewart AJ; School of Medicine, University of St Andrews, St. Andrews KY16 9TF, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 23; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Hemostatics*
Heparin*/pharmacology
Heparin*/metabolism
Anticoagulants ; Fibrinogen/metabolism ; Fibronectins ; Glycosaminoglycans ; Heparin, Low-Molecular-Weight/pharmacology ; Thrombin/chemistry ; Zinc/metabolism
Czasopismo naukowe
Tytuł:
Identification and characterization of a novel heparinase PCHepII from marine bacterium Puteibacter caeruleilacunae.
Autorzy:
Lu D; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China.
Wang L; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China.
Ning Z; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China.
Li Z; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China.
Li M; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China.
Jia Y; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China.
Zhang Q; School of Life Science and Technology, Weifang Medical University, 7166 Baotong West Street, Weifang, 261053, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 17; Vol. 13 (1), pp. 20112. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/metabolism
Heparitin Sulfate*/metabolism
Heparin Lyase/genetics ; Heparin Lyase/metabolism ; Bacteroidetes/metabolism ; Oligosaccharides/chemistry
Czasopismo naukowe
Tytuł:
Is low-molecular-weight heparin superior to aspirin for VTE prophylaxis?
Autorzy:
Rose M; University of Tennessee, Chattanooga Family, Medicine Residency Program.
Pang N; University of Tennessee, Chattanooga Family, Medicine Residency Program.
Conway S; University of Tennessee, Chattanooga Family, Medicine Residency Program.
Pokaż więcej
Źródło:
The Journal of family practice [J Fam Pract] 2023 Nov; Vol. 72 (9), pp. E14-E16.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Venous Thromboembolism*/prevention & control
Venous Thromboembolism*/drug therapy
Humans ; Aspirin/therapeutic use ; Anticoagulants/therapeutic use ; Enoxaparin/therapeutic use ; Heparin
Czasopismo naukowe
Tytuł:
Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial.
Autorzy:
Wang C; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Ning YC; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Song LP; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Li PJ; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Wang FH; Department of Emergency, PLA Rocket Force Characteristic Medical Center, Beijing, China.
Ding MX; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Jiang L; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Wang M; Department of Intensive Care Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Pei QQ; Department of General Practice, Aerospace Center Hospital, Beijing, China.
Hu SM; Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China .; Beijing Key Laboratory of Neuromodulation, Beijing, China.; Institute of Sleep and Consciousness Disorders, Center of Epilepsy, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China.
Wang H; Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China .; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 Oct 25; Vol. 13 (10), pp. e069742. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Venous Thromboembolism*/drug therapy
Humans ; Anticoagulants/therapeutic use ; Critical Illness/therapy ; Enoxaparin/therapeutic use ; Heparin ; Randomized Controlled Trials as Topic ; Factor Xa Inhibitors/blood
Czasopismo naukowe
Tytuł:
Low-molecular-weight heparin is superior to unfractionated heparin in lowering the risk of venous thromboembolism after traumatic lower extremity amputation.
Autorzy:
Argandykov D; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Proaño-Zamudio JA; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Lagazzi E; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Rafaqat W; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Abiad M; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Renne AM; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Paranjape CN; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Kaafarani HMA; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Velmahos GC; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA.
Hwabejire JO; Division of Trauma, Emergency Surgery & Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA. Electronic address: .
Pokaż więcej
Źródło:
Surgery [Surgery] 2023 Oct; Vol. 174 (4), pp. 1026-1033. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/therapeutic use
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Humans ; Child ; Adult ; Heparin, Low-Molecular-Weight/therapeutic use ; Anticoagulants/therapeutic use ; Amputation, Surgical/adverse effects ; Lower Extremity/surgery
Czasopismo naukowe
Tytuł:
A turn-on fluorescence sensor for detection of heparinase with heparin templated aggregation of tetracationic porphyrin derivative.
Autorzy:
Pandey SP; Amity Institute of Biotechnology, Amity University Maharashtra - Mumbai - Pune Expressway, Bhatan, Panvel, Maharashtra 410206, India.
Singh PK; Radiation & Photochemistry Division, Bhabha Atomic Research Centre, Mumbai 400 085, India; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400085, India. Electronic address: .
Jha P; Department of Biological Sciences, Sunandan Divatia School of Science, NMIMS Deemed to be University, Vile Parle (West), Mumbai 400056, India.
Jobby R; Amity Institute of Biotechnology, Amity University Maharashtra - Mumbai - Pune Expressway, Bhatan, Panvel, Maharashtra 410206, India; Amity Centre of Excellence in Astrobiology, Amity University Maharashtra - Pune Expressway, Bhatan, Panvel, Mumbai, Maharashtra 410206, India. Electronic address: .
Pokaż więcej
Źródło:
International journal of biological macromolecules [Int J Biol Macromol] 2023 Sep 30; Vol. 249, pp. 125934. Date of Electronic Publication: 2023 Jul 22.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/chemistry
Anticoagulants*/pharmacology
Animals ; Heparin Lyase/chemistry ; Heparin, Low-Molecular-Weight/chemistry ; Chondroitin Sulfates/chemistry ; Sulfates ; Mammals
Czasopismo naukowe
Tytuł:
Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) - a promising target for the immunotherapy of cancer.
Autorzy:
Lopez V; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Schuh HJM; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, Bonn, Germany.
Mirza S; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Vaaßen VJ; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Schmidt MS; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, Bonn, Germany.
Sylvester K; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Idris RM; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Renn C; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Schäkel L; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Pelletier J; Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Sévigny J; Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.; Départment de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Quebec, QC, Canada.
Naggi A; Institute for Chemical and Biochemical Research 'G. Ronzoni', Milan, Italy.
Scheffler B; DKFZ Division Translational Neurooncology at the West German Cancer Center (WTZ), DKTK Partner site, University Hospital Essen and German Cancer Research Center, Heidelberg, Germany.
Lee SY; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Bendas G; Pharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, Bonn, Germany.
Müller CE; Pharmaceutical Institute, Pharmaceutical and Medicinal Chemistry, University of Bonn, Bonn, Germany.; PharmaCenter Bonn, University of Bonn, Bonn, Germany.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Aug 29; Vol. 14, pp. 1173634. Date of Electronic Publication: 2023 Aug 29 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heparin*/pharmacology
Glioma*
Humans ; Immunotherapy ; Anticoagulants ; Heparin, Low-Molecular-Weight/pharmacology ; Heparin, Low-Molecular-Weight/therapeutic use
Czasopismo naukowe
Tytuł:
Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients.
Autorzy:
Buckley MS; Department of Pharmacy, Banner University Medical Center Phoenix, Phoenix, Arizona, USA.
Benanti GE; Department of Pharmacy, Loyola University Medical Center, Maywood, Illinois, USA.
Gilbert B; Department of Pharmacy, Wesley Medical Center, Wichita, Kansas, USA.
Meckel J; Department of Pharmacy, Banner University Medical Center Phoenix, Phoenix, Arizona, USA.
Dzierba AL; Department of Pharmacy, New York-Presbyterian Hospital, New York, New York, USA.
MacLaren R; Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
Pokaż więcej
Źródło:
Pharmacotherapy [Pharmacotherapy] 2023 Aug; Vol. 43 (8), pp. 795-803. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/adverse effects
COVID-19*
Humans ; Adult ; Thrombelastography ; Retrospective Studies ; Critical Illness ; Factor Xa Inhibitors/therapeutic use ; Partial Thromboplastin Time ; Heparin, Low-Molecular-Weight ; Anticoagulants/therapeutic use
Czasopismo naukowe
Tytuł:
Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
Autorzy:
Mu F; Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730000, China.
Wang M; Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730000, China.
Huang J; Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730000, China.
Wang F; Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730000, China. Electronic address: ery_.
Pokaż więcej
Źródło:
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2023 Aug; Vol. 287, pp. 29-35. Date of Electronic Publication: 2023 May 27.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Heparin, Low-Molecular-Weight*/adverse effects
Abortion, Habitual*/drug therapy
Abortion, Habitual*/prevention & control
Pregnancy ; Female ; Humans ; Fondaparinux/adverse effects ; Anticoagulants/adverse effects ; Pregnancy Outcome ; Birth Weight ; Heparin
Czasopismo naukowe
Tytuł:
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration.
Autorzy:
Xu L; Department of Nephrology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chineses Academy of Medical Sciences, Beijing, People's Republic of China.
Sun Y; Department of Nephrology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chineses Academy of Medical Sciences, Beijing, People's Republic of China.
Wang S; Department of Nephrology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chineses Academy of Medical Sciences, Beijing, People's Republic of China.
Li C; Department of Laboratory Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, NO. 1 DaHua Road, Dong Dan, Beijing, 100730, People's Republic of China. .
Mao Y; Department of Nephrology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chineses Academy of Medical Sciences, Beijing, People's Republic of China. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2023 Aug; Vol. 102 (8), pp. 2251-2256. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Heparin, Low-Molecular-Weight*/therapeutic use
Hemofiltration*
Humans ; Anticoagulants/therapeutic use ; Renal Dialysis ; Blood Coagulation ; Heparin ; Factor Xa Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Digital-like Enzyme Inhibition Mechanism-Based Strategy for the Digital Sensing of Heparin-Specific Biomarkers.
Autorzy:
Fan W; Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education; Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an, Shaanxi Province 710119, P. R. China.
Ren W; Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education; Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an, Shaanxi Province 710119, P. R. China.
Jia D; Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education; Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an, Shaanxi Province 710119, P. R. China.
Shi J; Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education; Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an, Shaanxi Province 710119, P. R. China.
Liu C; Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education; Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry & Chemical Engineering, Shaanxi Normal University, Xi'an, Shaanxi Province 710119, P. R. China.
Pokaż więcej
Źródło:
Analytical chemistry [Anal Chem] 2023 Sep 12; Vol. 95 (36), pp. 13690-13697. Date of Electronic Publication: 2023 Aug 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heparin*
Coloring Agents*
Heparin Lyase ; Biomarkers ; DNA Nucleotidylexotransferase ; Phosphoric Monoester Hydrolases ; Polynucleotide 5'-Hydroxyl-Kinase
Czasopismo naukowe
Tytuł:
Evaluation of Activated Clotting Times With a Heparin Reversal Protocol Designed to Conserve Protamine During Drug Shortages: A Retrospective, Cohort Study.
Autorzy:
Fabbro M 2nd; Department of Anesthesiology, Perioperative Medicine & Pain Management, University of Miami, Miller School of Medicine, Miami, FL. Electronic address: .
Salas ASL; Department of Anesthesiology, Perioperative Medicine & Pain Management, University of Miami, Miller School of Medicine, Miami, FL.
Parker KN; University of Miami, Miller School of Medicine, Miami, FL.
Lamelas J; Department of Surgery, University of Miami, Miller School of Medicine, Miami, FL.
Epstein RH; Department of Anesthesiology, Perioperative Medicine & Pain Management, University of Miami, Miller School of Medicine, Miami, FL.
Pokaż więcej
Źródło:
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2023 Sep; Vol. 37 (9), pp. 1618-1623. Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heparin*
Protamines*
Humans ; Adolescent ; Retrospective Studies ; Cohort Studies ; Blood Coagulation Tests ; Heparin Antagonists ; Cardiopulmonary Bypass/methods
Czasopismo naukowe
Tytuł:
Resistance to unfractionated heparin in the ICU: evaluation and management options.
Autorzy:
Levy JH; Departments of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University School of Medicine, Duke University Medical Center, 2301 Erwin Rd., 5691H HAFS, Box 3094, Durham, NC, 27710, USA. .
Frere C; Department of Hematology, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Paris, France.
Koster A; Institute of Anesthesiology and Pain Medicine, Heart and Diabetes Center NRW Bad Oeynhausen, Ruhr University Bochum, Bad Oeynhausen, Germany.
Pokaż więcej
Źródło:
Intensive care medicine [Intensive Care Med] 2023 Aug; Vol. 49 (8), pp. 1005-1007. Date of Electronic Publication: 2023 Jun 06.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/therapeutic use
Anticoagulants*/therapeutic use
Humans ; Heparin, Low-Molecular-Weight ; Intensive Care Units
Czasopismo naukowe
Tytuł:
Effects of low-dose intravenous heparin therapy in aneurysmal subarachnoid hemorrhage: a randomized controlled clinical trial protocol.
Autorzy:
Zhang Y; Department of Neurology, ShenZhen BaoAn People's Hospital, ShenZhen, China.
Hu J; Department of Neurosurgery, ShenZhen BaoAn People's Hospital, ShenZhen, China. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Jul 08; Vol. 24 (1), pp. 447. Date of Electronic Publication: 2023 Jul 08.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Heparin*/adverse effects
Subarachnoid Hemorrhage*/diagnosis
Subarachnoid Hemorrhage*/drug therapy
Humans ; Heparin, Low-Molecular-Weight/therapeutic use ; Retrospective Studies ; Anticoagulants/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives.
Autorzy:
Levy JH; Departments of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: .
Ghadimi K; Departments of Anesthesiology and Critical Care, Duke University School of Medicine, Durham, North Carolina, USA.
Kizhakkedathu JN; Centre for Blood Research, Department of Pathology and Laboratory Medicine, The School of Biomedical Engineering, The University of British Columbia, Vancouver, British Colombia, Canada.
Iba T; Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Jul; Vol. 21 (7), pp. 1714-1723. Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Protamines*
Heparin*
Humans ; Male ; Anticoagulants/therapeutic use ; Heparin Antagonists/adverse effects ; Semen ; Cardiopulmonary Bypass/adverse effects
Czasopismo naukowe
Tytuł:
Continuation of therapeutic dose heparin for critically ill patients with COVID-19.
Autorzy:
Bradbury CA; University of Bristol, Bristol, UK. .; Bristol Haematology and Oncology Centre, Horfield Road, Bristol, BS2 8ED, UK. .
Lawler PR; Peter Munk Cardiac Centre at University Health Network, Toronto, Canada.; University of Toronto, Toronto, Canada.
McVerry BJ; University of Pittsburgh, Pittsburgh, USA.
Zarychanski R; University of Manitoba, Winnipeg, Canada.
Pokaż więcej
Corporate Authors:
REMAP-C. A. P. Investigators
Źródło:
Intensive care medicine [Intensive Care Med] 2023 Jul; Vol. 49 (7), pp. 873-875. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Letter
MeSH Terms:
Heparin*/therapeutic use
COVID-19*
Humans ; Critical Illness/therapy ; Anticoagulants/therapeutic use ; SARS-CoV-2 ; Heparin, Low-Molecular-Weight
Opinia redakcyjna
Tytuł:
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update.
Autorzy:
Vitiello A; Pharmaceutical Department, Usl Umbria 1, XIV Settembre Street, 06132, Perugia, Italy.
Ferrara F; Pharmaceutical Department, Asl Napoli 3 SUD, Dell'Amicizia Street, 80035, Naples, Nola, Italy. .
Pokaż więcej
Źródło:
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2023 Apr; Vol. 37 (2), pp. 277-281. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Heparin, Low-Molecular-Weight*/pharmacology
Heparin, Low-Molecular-Weight*/therapeutic use
COVID-19*
Animals ; Heparin/adverse effects ; Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Heparin Rebound: An In-Depth Review.
Autorzy:
Stone ME; Icahn School of Medicine at Mount Sinai, New York, NY.
Vespe MW; Icahn School of Medicine at Mount Sinai, New York, NY.
Pokaż więcej
Źródło:
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2023 Apr; Vol. 37 (4), pp. 601-612. Date of Electronic Publication: 2022 Dec 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Heparin*
Protamines*
Humans ; Blood Coagulation Tests ; Postoperative Hemorrhage ; Heparin Antagonists ; Cardiopulmonary Bypass ; Anticoagulants
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies